30 Chapter 1 31. Hewitt SC, Korach KS. Estrogen Receptors: New Directions in the New Millennium. Endocr Rev 2018;39:664-675. 32. Welch KM, Brandes JL, Berman NE. Mismatch in how oestrogen modulates molecular and neuronal function may explain menstrual migraine. Neurol Sci 2006;27 Suppl 2:S190-192. 33. Anckaert E, Jank A, Petzold J, et al. Extensive monitoring of the natural menstrual cycle using the serum biomarkers estradiol, luteinizing hormone and progesterone. Pract Lab Med 2021;25:e00211. 34. Rustichelli C, Bellei E, Bergamini S, et al. Serum levels of allopregnanolone, progesterone and testosterone in menstrually-related and postmenopausal migraine: A cross-sectional study. Cephalalgia 2020;40:1355-1362. 35. Valdemarsson S, Edvinsson L, Hedner P, Ekman R. Hormonal influence on calcitonin generelated peptide in man: effects of sex difference and contraceptive pills. Scand J Clin Lab Invest 1990;50:385-388. 36. Raffaelli B, Storch E, Overeem LH, et al. Sex Hormones and Calcitonin Gene–Related Peptide in Women With Migraine. Neurology 2023;100:e1825-e1835. 37. Eikermann-Haerter K, Dileköz E, Kudo C, et al. Genetic and hormonal factors modulate spreading depression and transient hemiparesis in mouse models of familial hemiplegic migraine type 1. J Clin Invest 2009;119:99-109. 38. Krause DN, Warfvinge K, Haanes KA, Edvinsson L. Hormonal influences in migraine - interactions of oestrogen, oxytocin and CGRP. Nat Rev Neurol 2021;17:621-633. 39. Sandweiss AJ, Cottier KE, McIntosh MI, et al. 17-β-Estradiol induces spreading depression and pain behavior in alert female rats. Oncotarget 2017;8:114109-114122. 40. van den Maagdenberg AMJM, Pietrobon D, Pizzorusso T, et al. A Cacna1a Knockin Migraine Mouse Model with Increased Susceptibility to Cortical Spreading Depression. Neuron 2004;41:701-710. 41. Sachs M, Pape HC, Speckmann EJ, Gorji A. The effect of estrogen and progesterone on spreading depression in rat neocortical tissues. Neurobiol Dis 2007;25:27-34. 42. Brennan KC, Romero-Reyes M, López Valdés HE, Arnold AP, Charles AC. Reduced threshold for cortical spreading depression in female mice. Annals of Neurology 2007;61:603-606. 43. van Welie RF, van Welie FC, de Vries Lentsch S, Dahan A, van Velzen M, Terwindt GM. Characterizing opioid use in a Dutch cohort with migraine. Cephalalgia 2023;43:3331024231174160. 44. Karsan N, Goadsby PJ. CGRP mechanism antagonists and migraine management. Curr Neurol Neurosci Rep 2015;15:25. 45. Bigal ME, Bordini CA, Antoniazzi AL, Speciali JG. The triptan formulations: a critical evaluation. Arq Neuropsiquiatr 2003;61:313-320. 46. Ashina S, Terwindt GM, Steiner TJ, et al. Medication overuse headache. Nat Rev Dis Primers 2023;9:5.
RkJQdWJsaXNoZXIy MjY0ODMw